跳至主要内容
临床试验/JPRN-jRCT1032200111
JPRN-jRCT1032200111招募中2 期

Safety and efficacy of transjugular biopsy using the AcquireTM Endoscopic Ultrasound Fine Needle Biopsy Device

Kato Naoya0 个研究点目标入组 12 人开始时间: 2020年9月9日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
Kato Naoya
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1) Patients who scheduled for a transvenous liver biopsy or transvenous renal biopsy due to chronic liver disease with/without renal impairment
  • 2) Child-Pugh score A or B
  • 3) Age is 20 years or older (any gender)
  • 4) Patients who have been fully informed of and have obtained the written consent of their own free will to participate in the study.

排除标准

  • 1) The patient who has one of the following cardiac diseases
  • a) Heart failure of NYHA class 3 or higher.
  • b) Current symptomatic coronary artery disease or a history of myocardial infarction within 4 weeks prior to enrollment.
  • 2) Serious and active infection (CTCAE version 4.0 Grade 3 or higher)
  • 3) Pregnant or lactating women and those who may or will become pregnant (if pregnancy is suspected, a pregnancy test should be performed).
  • 4) There is a possibility of compromising patient safety or difficulty in complying with the study protocol.

研究者

发起方
Kato Naoya

相似试验